Cargando…
Targeting the endogenous cannabinoid system to treat neuropathic pain
Autores principales: | Lau, Benjamin K., Vaughan, Christopher W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939704/ https://www.ncbi.nlm.nih.gov/pubmed/24624084 http://dx.doi.org/10.3389/fphar.2014.00028 |
Ejemplares similares
-
Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain
por: Casey, Sherelle L., et al.
Publicado: (2018) -
R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids
por: Bishay, Philipp, et al.
Publicado: (2010) -
The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area
por: Zhang, Hong, et al.
Publicado: (2021) -
Immunotherapy targeting cytokines in neuropathic pain
por: Lees, Justin G., et al.
Publicado: (2013) -
Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain
por: Hossain, Mohammad Zakir, et al.
Publicado: (2020)